Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance
- 11 January 2010
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (4) , 1321-1326
Abstract
We propose a systematic approach for a better understanding of how HIV viruses employ various combinations of mutations to resist drug treatments, which is critical to developing new drugs and optimizing the use of existing drugs. By probabilistically modeling mutations in the HIV-1 protease or reverse transcriptase (RT) isolated from drug-treated patients, we present a statistical procedure that first detects mutation combinations associated with drug resistance and then infers detailed interaction structures of these mutations. The molecular basis of our statistical predictions is further studied by using molecular dynamics simulations and free energy calculations. We have demonstrated the usefulness of this systematic procedure on three HIV drugs, (Indinavir, Zidovudine, and Nevirapine), discovered unique interaction features between viral mutations induced by these drugs, and revealed the structural basis of such interactions.Keywords
This publication has 25 references indexed in Scilit:
- Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B proteaseBMC Bioinformatics, 2009
- Bioinformatics prediction of HIV coreceptor usageNature Biotechnology, 2007
- Bayesian inference of epistatic interactions in case-control studiesNature Genetics, 2007
- Mining complex genotypic features for predicting HIV-1 drug resistanceBioinformatics, 2007
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceAIDS, 2007
- Genotypic predictors of human immunodeficiency virus type 1 drug resistanceProceedings of the National Academy of Sciences of the United States of America, 2006
- Bioinformatics-assisted anti-HIV therapyNature Reviews Microbiology, 2006
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Kinetic, Stability, and Structural Changes in High-resolution Crystal Structures of HIV-1 Protease with Drug-resistant Mutations L24I, I50V, and G73SJournal of Molecular Biology, 2005
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995